|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 280, Issue 40, 34088-34095, October 7, 2005
Ubiquilin-1 Regulates Nicotine-induced Up-regulation of Neuronal Nicotinic Acetylcholine Receptors*![]() ![]() ![]() 1
From the
Departments of
Chronic exposure to nicotine, as in tobacco smoking, up-regulates nicotinic acetylcholine receptor surface expression in neurons. This up-regulation has been proposed to play a role in nicotine addiction and withdrawal. The regulatory mechanisms behind nicotine-induced up-regulation of surface nicotinic acetylcholine receptors remain to be determined. It has recently been suggested that nicotine stimulation acts through increased assembly and maturation of receptor subunits into functional pentameric receptors. Studies of muscle nicotinic acetylcholine receptors suggest that the availability of unassembled subunits in the endoplasmic reticulum can be regulated by the ubiquitin-proteosome pathway, resulting in altered surface expression. Here, we describe a role for ubiquilin-1, a ubiquitin-like protein with the capacity to interact with both the proteosome and ubiquitin ligases, in regulating nicotine-induced up-regulation of neuronal nicotinic acetylcholine receptors. Ubiquilin-1 interacts with unassembled
Received for publication, June 22, 2005 , and in revised form, July 19, 2005. * This work was supported in part by the Duke University Medical Center Medical Scientist Training Program (to M. B. F.) and a postdoctoral fellowship from the Ruth K. Broad Biomedical Research Foundation, Inc. (to S. Z.). This work was also supported by the Alfred P. Sloan Research Fellowship, the Klingenstein Fellowship in the Neurosciences, the EJLB Foundation's Scholar Research Program, Scientist Development Grant 0230064N from the American Heart Association, and National Institute of Health Grant NS042609 (to G. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 To whom correspondence should be addressed: Dept. of Neurobiology, Box 3209, Duke University Medical Center, Research Drive, Durham, NC 27710. Tel.: 919-668-1657; Fax: 919-668-1891; E-mail: feng{at}neuro.duke.edu.
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||